Envision Healthcare Holdings

Envision Healthcare — Debt Investor Presentation (October 2015)

35 slides from Envision Healthcare's debt investor presentation, Oct 28, 2015

  1. Slide 1: Forward-Looking Statements

    FORWARD-LOOKING STATEMENTS SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INFORMATION Forward-Looking Statements Certain statements and information in this presentation may be deemed to be "forward-looking statements" of Envision Healthcare Holdings, Inc. (“Envision”) within the meaning of th

  2. Slide 2: Non-GAAP Financial Measures

    NON-GAAP FINANCIAL MEASURES Presentation of Non-GAAP Measures This presentation includes statements regarding expected Adjusted EBITDA and Rural/Metro Pro Forma Adjusted EBITDA, which are not financial measures calculated and presented in accordance with generally accepted accounting principles in t

  3. Slide 3: Non-GAAP Financial Measures

    NON-GAAP FINANCIAL MEASURES Presentation of Non-GAAP Measures This presentation includes statements regarding expected Adjusted EBITDA and Rural/Metro Pro Forma Adjusted EBITDA, which are not financial ‘measures calculated and presented in accordance with generally accepted accounting principles in

  4. Slide 4: Transaction overview

    Transaction overview 5 Envision Healthcare Holdings, Inc. (“Envision” or the “Company”) (NYSE: EVHC) is a leading provider of physician-led, outsourced medical services in the U.S. with more than 35,000 employees and affiliated clinicians For the LTM period ended 9/30/2015, Envision generated net re

  5. Slide 5: Sources and Uses / As Adjusted Capitalization

    SOURCES AND USES / AS ADJUSTED CAPITALIZATION Sources and Uses As Adjusted Capitalization Note: Adjusted EBITDA and Rural/Metro Pro Forma Adjusted EBITDA as defined in Non-GAAP Financial Measures. Prior periods have been adjusted accordingly for comparability purposes. Rural/Metro Pro Forma Adjusted

  6. Slide 6: Summary Terms

    SUMMARY TERMS Borrower: Envision Healthcare Corporation (Borrower under the existing Term Loan) Facility: $750 million Term Loan B-2 Facility (the “Term Loan B”) Existing Incremental Facilities: $250 million, plus unlimited amounts provided Consolidated First Lien Net Leverage Ratio does not exceed

  7. Slide 7: Transaction Timetable

    October 2015 S M T W T F S 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 TRANSACTION TIMETABLE Date Event October 28 Bank Meeting November 4 Commitments Due Week of November 9 Close and Fund Holiday Key Date November 2015 S M T W T F S 1 2 3 4 5 6 7 8 9 10 11 12

  8. Slide 8: Transaction Timetable

    TRANSACTION TIMETABLE October 2015 November 2015 Ss oM tT WT FS SMT WTF S 1203 12 3MBs 6 7 HE tiotiay Key Dato Date Event October 28 = Bank Meeting November 4 = Commitments Due Week of November 9 = Close and Fund == Envision 8 M@Mvear ARE

  9. Slide 9: Investment Highlights

    INVESTMENT HIGHLIGHTS 10 Leading Player in Large and Growing Outsourced Healthcare Services Markets Positioned at the Nexus of Rapidly Evolving Healthcare Landscape Differentiated, Integrated Service Model Across the Patient Continuum History of Strong Revenue and EBITDA Growth with Stable Cash Flow

  10. Slide 10: Key Highlights

    KEY HIGHLIGHTS Note: Adjusted EBITDA as defined in Non-GAAP Financial Measures. Prior periods have been adjusted accordingly for comparability purposes. See reconciliation in supplemental materials. $9.7M of insurance reserve adjustments for two significantly higher than expected malpractice cases f

  11. Slide 11: Positioned at the Nexus of the Evolving Landscape

    POSITIONED AT THE NEXUS OF THE EVOLVING LANDSCAPE 12 Healthcare reform driving new models of delivery and reimbursement Population health driving changes in managing care across the patient continuum Integrated care models improve outcomes, reduce cost Movement toward market centricity (space and sc

  12. Slide 12: Leading Provider of Healthcare Services Across a Patient Continuum

    A leading provider and manager of community-based medical transportation services A leading provider of integrated physician services to healthcare facilities A comprehensive provider of physician-led population health management solutions Over 50 Year History of Pioneering the Delivery of Care` LEA

  13. Slide 13: Leading Outsourced Provider with National Scale and Strong Local Presence

    LEADING OUTSOURCED PROVIDER WITH NATIONAL SCALE AND STRONG LOCAL PRESENCE AMR Operations – (38 States) EmCare Operations – (41 States) Evolution Health – (8 States) Top Market Centricity Opportunities Leading Market Position Provides Significant Competitive Advantages Benefits of Scale and Scope Rev

  14. Slide 14: Multiple Levers to Drive Strong and Consistent Growth

    Continued development of additional services that enhance the patient continuum Either de novo or through acquisitions MULTIPLE LEVERS TO DRIVE STRONG AND CONSISTENT GROWTH Same Store Organic Growth Net New Contracts Existing Services Integrated services / cross-selling Proven track record improving

  15. Slide 15: EmCare: Leading Outsourced Provider of Integrated Facility-Based Physician Services

    EMCARE: LEADING OUTSOURCED PROVIDER OF INTEGRATED FACILITY-BASED PHYSICIAN SERVICES 1. Management estimates of 2014 market size and EmCare outsourced market share. Integrated services offering Demonstrated track record of improving metrics High quality service drives patient and physician satisfacti

  16. Slide 16: EmCare: Robust Growth Platform with Significant Momentum

    EmCare Key Growth Drivers EMCARE: ROBUST GROWTH PLATFORM WITH SIGNIFICANT MOMENTUM Long-Term History of Highly Visible, Recurring Revenue with Recent Acceleration in Growth Organic Growth 13.0% 15.5% 17.3% 12.7% Organic EmCare Revenue Growth Breakdown1 Share Gains from Local and Regional Groups Expa

  17. Slide 17: AMR: Leading Outsourced Provider of Community-Based Medical Transportation

    Substantial scale advantages in ambulance services “AMR Medicine” drives best of class clinical outcomes and improved patient experience AMR Competitive Advantages AMR: LEADING OUTSOURCED PROVIDER OF COMMUNITY-BASED MEDICAL TRANSPORTATION SERVICES A Leader in Ambulance Market with Growing Positions

  18. Slide 18: AMR: Business Realignment Accelerated Growth, Led to Margin Improvements

    Positioned for Accelerated Revenue Growth AMR: BUSINESS REALIGNMENT ACCELERATED GROWTH, LED TO MARGIN IMPROVEMENTS Well-Positioned for Accelerated Revenue Growth and Continued Margin Improvements Increasing New Contract Win Rates Strengthened AMR Management Team Proven Superior Clinical Outcomes (AM

  19. Slide 19: Evolution Health overview

    Specializes in physician-led, population management services in the post-acute, home, mobile environment Focus on high risk, high cost and vulnerable populations with advanced illness and multiple chronic conditions Over 2,200 dedicated caregivers, and rapidly growing Leverages EmCare and AMR compet

  20. Slide 20: Evolution Health: Integration Driven Growth with Demonstrated Market Traction

    Strategic Deployment for Market Centricity EVOLUTION HEALTH: INTEGRATION DRIVEN GROWTH WITH DEMONSTRATED MARKET TRACTION Strategic Innovation with Strong Market Traction and Recent Acceleration in Growth Robust Clinical Care Model Risk Arrangements, Gain Sharing, Bundled Payments, Capitation Modular

  21. Slide 21: 2015 Highlights

    2015 HIGHLIGHTS 22 Envision’s 2015 Guidance: Adjusted EBITDA of $600M - $605M and Adjusted EPS of $1.28 - $1.30 8 to 9 percent implied Adjusted EBITDA growth includes lost Medicaid parity revenue at ~80% Adjusted EBITDA margin, offset by 2015 acquisitions EmCare acquisition of Emergency Medical Asso

  22. Slide 22: 2015 Highlights

    2015 HIGHLIGHTS 22 Envision's 2015 Guidance: > Adjusted EBITDA of $600M - $605M and Adjusted EPS of $1.28 - $1.30 — 8 to 9 percent implied Adjusted EBITDA growth includes lost Medicaid parity revenue at ~80% Adjusted EBITDA margin, offset by 2015 acquisitions EmCare acquisition of Emergency Medical

  23. Slide 23: Envision to Acquire Rural/Metro

    ENVISION TO ACQUIRE RURAL/METRO 24 Strategic Rationale Creates a leading outsourced healthcare transportation services company in the U.S. Combined company will offer superior services in: Emergency “911” Inter-facility Managed transportation services Non-government fire services (subscription) Comb

  24. Slide 24: Rural/Metro: Established ambulance and fire services provider

    Established ambulance and fire services provider 25 Net Revenue ($ in Millions) Adjusted EBITDA ($ in millions) Ambulance Services Segment Overview Leading provider of emergency and non-emergency ambulance services in the U.S. Nearly 100 exclusive contracts to provide 911 emergency services Thousand

  25. Slide 25: Expanding on Our Regional Presence

    Expanding on Our regional Presence 26 AMR Operations AMR / Rural/Metro Overlap Rural/Metro

  26. Slide 26: Pro Forma Financials LTM 9/30/2015

    Pro forma financials 27 LTM 9/30/2015 Revenue LTM 9/30/15 Pro Forma Adjusted EBITDA ($ in millions) Note: Adjusted EBITDA as defined in Non-GAAP Financial Measures. Prior periods have been adjusted accordingly for comparability purposes. Rural/Metro Pro Forma Adjusted EBITDA includes pro forma impac

  27. Slide 27: Pro Forma Financials

    PRO FORMA FINANCIALS (Sn mtions) M 9/30/2015 Revenue TM 9/30/15 Pro Forma Adjusted EBITD. | sss | $5,722 Envision Rural/Metro Total Envision Rural/Metro. ‘Synergies Total ew “Gunes ETOA notch po foma moat canter ager, src amenaners coer aduronerromeed axcegamorrare ad @ ® Envision 27 mootena hye mon

  28. Slide 28: Strong Historical Revenue and EBITDA Growth

    Net Revenue STRONG HISTORICAL REVENUE AND EBITDA GROWTH ’05-’14 CAGR: 10.4% ’05-’14 CAGR: 15.5% Note: $ in millions. Adjusted EBITDA as defined in Non-GAAP Financial Measures. Prior periods have been adjusted accordingly for comparability purposes. See reconciliation in supplemental materials. 2008

  29. Slide 29: Continued Revenue and EBITDA Growth in 2015

    CONTINUED REVENUE AND EBITDA GROWTH IN 2015 30 % Margin EmCare 12.5% 10.0% AMR 12.0% 12.9% Envision 12.3% 10.9% % Growth EmCare 29.1% AMR 10.4% Envision 22.4% Net Revenue Adjusted EBITDA Q3 2015 Financial Results Continued Strong Performance in 2015 Note: $ in millions. Adjusted EBITDA as defined in

  30. Slide 30: Strong and Stable Cash Flows

    STRONG AND STABLE CASH FLOWS 31 Note: DSO calculated based on last quarter of indicated period. Days Sales Outstanding Net CapEx as a % of Revenue Contract Retention Rate Top 10 Customers Tenure Recurring Revenue, Attractive Operating Margins and Relatively Low Capital Expenditure and Working Capita

  31. Slide 31: Historical Ability to Reduce Leverage

    HISTORICAL ABILITY TO REDUCE LEVERAGE 32 Note: $ in millions. Cash balance includes cash and all near cash items. Total Net Leverage-to-LTM Adjusted EBITDA Multiples Strong Cash Flow Supports De-Levering Key Events: IPO CD&R Acquisition Recap IPO Note Offering Acquisition Funding Pro Forma 3.2x 0.4x

  32. Slide 32: Historical Ability to Reduce Leverage

    HISTORICAL ABILITY TO REDUCE LEVERAGE Total Net Leverage: 'M Adjusted EBITDA Multiples 1 1 1 1 It 1 ' I 1 1 1 1 i 1 Il 1 1 1 I 1 i 1 I fl 1 1 1 I 1 1 ' 1 ' 1 ' 1 ' 1 1 1 2012 1 1 1 1 1 1 1 1 1 1 1 1 1 1 ' 42x 1 1 1 1 1 2008 zo 22011 2011 03.2012 32013 sz 0M a8 2018 Key ‘oar Note ‘Acquistion Events:

  33. Slide 33: Envision Adjusted EBITDA Reconciliation

    ENVISION ADJUSTED EBITDA RECONCILIATION 1. 2005 related party management fees represent both Laidlaw and Onex management fees and 2013 includes $20M to terminate the CD&R consulting agreement Fiscal Year Ended December 31, ($ in millions) 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Net income

  34. Slide 34: Rural/Metro Adjusted EBITDA Reconciliation

    RURAL/METRO ADJUSTED EBITDA RECONCILIATION 1. Billing Restructuring Costs – Represents payroll related costs and temporary resources hired in excess of the stead state revenue cycle costs 2. Other – Represents non-recurring professional fees related to operational restructuring, IT projects for syst

  35. Slide 35: Rural/Metro Pro Forma Adjusted EBITDA Reconciliation

    RURAL/METRO PRO FORMA ADJUSTED EBITDA RECONCILIATION (ermtecs) tm 072015 Net Income (Loss) ($50.4) DOeprecation and amortzaton expense 330 Interest Expense 36 Income Tax Expense: G3) Discontinued Operations 00 Reported EBITDA si39 Iimpatrment of PPRE and Intangible assets 23 ‘Bing Restructuring Cost

Envision Healthcare Holdings — Debt Investor Presentation (October 2015) on 6ix